Galderma Group AG (SIX:GALD) is accelerating international expansion—advancing Nemluvio filings, rolling out Alastin across JPAC with Taiwan live and Japan, Singapore and South Korea launches planned, while preparing product lifecycles and joining the Swiss Market Index on Sept 21, 2026.
Previous Week Recap
- Galderma Expands Abroad, Nemluvio Filings: Galderma (GALD) expands geographically, advancing Nemluvio regulatory filings abroad, plans product launches and lifecycle management, and will join the Swiss Market Index on Sept 21, 2026.
- Alastin JPAC Rollout Planned: Galderma Group AG (GALD) rolls out Alastin in JPAC: available Taiwan, Japan launch planned; regulatory clearance secured for Singapore and South Korea with market entry set for Sept and Nov.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.